|
1
|
Fuster V, Rydén LE, Cannom DS, Crijns HJ,
Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe
JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS, Smith SC Jr,
Priori SG, Estes NA III, Ezekowitz MD, Jackman WM, January CT, Lowe
JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Jacobs AK,
Anderson JL, Albert N, Buller CE, Creager MA, Ettinger SM, Guyton
RA, Halperin JL, Hochman JS, Kushner FG, Ohman EM, Stevenson WG,
Tarkington LG and Yancy CW; American College of Cardiology
Foundation/American Heart Association Task Force. 2011 ACCF/AHA/HRS
focused updates incorporated into the ACC/AHA/ESC 2006 guidelines
for the management of patients with atrial fibrillation: a report
of the American College of Cardiology Foundation/American Heart
Association Task Force on practice guidelines. Circulation.
123:e269–e367. 2011.
|
|
2
|
Go AS, Hylek EM, Phillips KA, Chang Y,
Henault LE, Selby JV and Singer DE: Prevalence of diagnosed atrial
fibrillation in adults: national implications for rhythm management
and stroke prevention: the AnTicoagulation and Risk Factors in
Atrial Fibrillation (ATRIA) Study. JAMA. 285:2370–2375. 2001.
View Article : Google Scholar
|
|
3
|
Lloyd-Jones DM, Wang TJ, Leip EP, Larson
MG, Levy D, Vasan RS, D’Agostino RB, Massaro JM, Beiser A, Wolf PA
and Benjamin EJ: Lifetime risk for development of atrial
fibrillation: the Framingham Heart Study. Circulation.
110:1042–1046. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wolf PA, Abbott RD and Kannel WB: Atrial
fibrillation as an independent risk factor for stroke: the
Framingham Study. Stroke. 22:983–988. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Benjamin EJ, Wolf PA, D’Agostino RB,
Silbershatz H, Kannel WB and Levy D: Impact of atrial fibrillation
on the risk of death: the Framingham Heart Study. Circulation.
98:946–952. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nattel S: New ideas about atrial
fibrillation 50 years on. Nature. 415:219–226. 2002.PubMed/NCBI
|
|
7
|
Huang WJ, Zhou R, Zeng XR, Tan XQ, Cheng
ZH, Tang MH, Gou LT, Chen LJ, Tong AP, He Y and Yang JL:
Comparative proteomic analysis of atrial appendages from rheumatic
heart disease patients with sinus rhythm and atrial fibrillation.
Mol Med Rep. 4:655–661. 2011.PubMed/NCBI
|
|
8
|
Li H, Li S, Yu B and Liu S: Expression of
miR-133 and miR-30 in chronic atrial fibrillation in canines. Mol
Med Rep. 5:1457–1460. 2012.PubMed/NCBI
|
|
9
|
Cheng T, Wang XF, Hou YT and Zhang L:
Correlation between atrial fibrillation, serum amyloid protein A
and other inflammatory cytokines. Mol Med Rep. 6:581–584.
2012.PubMed/NCBI
|
|
10
|
Kim SM, Lee JH, Kim JR, Shin DG, Lee SH
and Cho KH: Female patients with atrial fibrillation have increased
oxidized and glycated lipoprotein properties and lower
apolipoprotein A-I expression in HDL. Int J Mol Med. 27:841–849.
2011.PubMed/NCBI
|
|
11
|
Darbar D, Herron KJ, Ballew JD, Jahangir
A, Gersh BJ, Shen WK, Hammill SC, Packer DL and Olson TM: Familial
atrial fibrillation is a genetically heterogeneous disorder. J Am
Coll Cardiol. 41:2185–2192. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fox CS, Parise H, D’Agostino RB Sr,
Lloyd-Jones DM, Vasan RS, Wang TJ, Levy D, Wolf PA and Benjamin EJ:
Parental atrial fibrillation as a risk factor for atrial
fibrillation in offspring. JAMA. 291:2851–2855. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ellinor PT, Yoerger DM, Ruskin JN and
MacRae CA: Familial aggregation in lone atrial fibrillation. Hum
Genet. 118:179–184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Arnar DO, Thorvaldsson S, Manolio TA,
Thorgeirsson G, Kristjansson K, Hakonarson H and Stefansson K:
Familial aggregation of atrial fibrillation in Iceland. Eur Heart
J. 27:708–712. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Junttila MJ, Raatikainen MJ, Perkiömäki
JS, Hong K, Brugada R and Huikuri HV: Familial clustering of lone
atrial fibrillation in patients with saddleback-type ST-segment
elevation in right precordial leads. Eur Heart J. 28:463–468. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Christophersen IE, Ravn LS,
Budtz-Joergensen E, Skytthe A, Haunsoe S, Svendsen JH and
Christensen K: Familial aggregation of atrial fibrillation: a study
in Danish twins. Circ Arrhythm Electrophysiol. 2:378–383. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang YQ, Zhang XL, Wang XH, Tan HW, Shi
HF, Fang WY and Liu X: Familial aggregation of lone atrial
fibrillation in the Chinese population. Intern Med. 49:2385–2391.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lubitz SA, Yin X, Fontes JD, Magnani JW,
Rienstra M, Pai M, Villalon ML, Vasan RS, Pencina MJ, Levy D,
Larson MG, Ellinor PT and Benjamin EJ: Association between familial
atrial fibrillation and risk of new-onset atrial fibrillation.
JAMA. 304:2263–2269. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brugada R, Tapscott T, Czernuszewicz GZ,
Marian AJ, Iglesias A, Mont L, Brugada J, Girona J, Domingo A,
Bachinski LL and Roberts R: Identification of a genetic locus for
familial atrial fibrillation. N Engl J Med. 336:905–911. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ellinor PT, Shin JT, Moore RK, Yoerger DM
and MacRae CA: Locus for atrial fibrillation maps to chromosome
6q14–16. Circulation. 107:2880–2883. 2003.PubMed/NCBI
|
|
21
|
Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang
Y, Xu WY, Jin HW, Sun H, Su XY, Zhuang QN, Yang YQ, Li YB, Liu Y,
Xu HJ, Li XF, Ma N, Mou CP, Chen Z, Barhanin J and Huang W: KCNQ1
gain-of-function mutation in familial atrial fibrillation. Science.
299:251–254. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Oberti C, Wang L, Li L, Dong J, Rao S, Du
W and Wang Q: Genome-wide linkage scan identifies a novel genetic
locus on chromosome 5p13 for neonatal atrial fibrillation
associated with sudden death and variable cardiomyopathy.
Circulation. 110:3753–3759. 2004. View Article : Google Scholar
|
|
23
|
Darbar D, Hardy A, Haines JL and Roden DM:
Prolonged signal-averaged P-wave duration as an intermediate
phenotype for familial atrial fibrillation. J Am Coll Cardiol.
51:1083–1089. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang X, Chen S, Yoo S, Chakrabarti S,
Zhang T, Ke T, Oberti C, Yong SL, Fang F, Li L, de la Fuente R,
Wang L, Chen Q and Wang QK: Mutation in nuclear pore component
NUP155 leads to atrial fibrillation and early sudden cardiac death.
Cell. 135:1017–1027. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang Y, Xia M, Jin Q, Bendahhou S, Shi J
and Chen Y, Liang B, Lin J, Liu Y, Liu B, Zhou Q, Zhang D, Wang R,
Ma N, Su X, Niu K, Pei Y, Xu W, Chen Z, Wan H, Cui J, Barhanin J
and Chen Y: Identification of a KCNE2 gain-of-function mutation in
patients with familial atrial fibrillation. Am J Hum Genet.
75:899–905. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lundby A, Ravn LS, Svendsen JH, Hauns S,
Olesen SP and Schmitt N: KCNE3 mutation V17M identified in a
patient with lone atrial fibrillation. Cell Physiol Biochem.
21:47–54. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ravn LS, Aizawa Y, Pollevick GD,
Hofman-Bang J, Cordeiro JM, Dixen U, Jensen G, Wu Y, Burashnikov E,
Haunso S, Guerchicoff A, Hu D, Svendsen JH, Christiansen M and
Antzelevitch C: Gain of function in IKs secondary to a mutation in
KCNE5 associated with atrial fibrillation. Heart Rhythm. 5:427–435.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hong K, Bjerregaard P, Gussak I and
Brugada R: Short QT syndrome and atrial fibrillation caused by
mutation in KCNH2. J Cardiovasc Electrophysiol. 16:394–396. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xia M, Jin Q, Bendahhou S, He Y, Larroque
MM and Chen Y, Zhou Q, Yang Y, Liu Y, Liu B, Zhu Q, Zhou Y, Lin J,
Liang B, Li L, Dong X, Pan Z, Wang R, Wan H, Qiu W, Xu W, Eurlings
P, Barhanin J and Chen Y: A Kir2.1 gain-of-function mutation
underlies familial atrial fibrillation. Biochem Biophys Res Commun.
332:1012–1019. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Delaney JT, Muhammad R, Blair MA, Kor K,
Fish FA, Roden DM and Darbar D: A KCNJ8 mutation associated with
early repolarization and atrial fibrillation. Europace.
14:1428–1432. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Olson TM, Alekseev AE, Liu XK, Park S,
Zingman LV, Bienengraeber M, Sattiraju S, Ballew JD, Jahangir A and
Terzic A: Kv1.5 channelopathy due to KCNA5 loss-of-function
mutation causes human atrial fibrillation. Hum Mol Genet.
15:2185–2191. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang Y, Li J, Lin X, Yang Y, Hong K, Wang
L, Liu J, Li L, Yan D, Liang D, Xiao J, Jin H, Wu J, Zhang Y and
Chen YH: Novel KCNA5 loss-of-function mutations responsible for
atrial fibrillation. J Hum Genet. 54:277–283. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Darbar D, Kannankeril PJ, Donahue BS,
Kucera G, Stubblefield T, Haines JL, George AL Jr and Roden DM:
Cardiac sodium channel (SCN5A) variants associated with atrial
fibrillation. Circulation. 117:1927–1935. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hodgson-Zingman DM, Karst ML, Zingman LV,
Heublein DM, Darbar D, Herron KJ, Ballew JD, de Andrade M, Burnett
JC Jr and Olson TM: Atrial natriuretic peptide frameshift mutation
in familial atrial fibrillation. N Engl J Med. 359:158–165. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jiang JQ, Shen FF, Fang WY, Liu X and Yang
YQ: Novel GATA4 mutations in lone atrial fibrillation. Int J Mol
Med. 28:1025–1032. 2011.PubMed/NCBI
|
|
36
|
Yang YQ, Wang MY, Zhang XL, Tan HW, Shi
HF, Jiang WF, Wang XH, Fang WY and Liu X: GATA4 loss-of-function
mutations in familial atrial fibrillation. Clin Chim Acta.
412:1825–1830. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang J, Sun YM and Yang YQ: Mutation
spectrum of the GATA4 gene in patients with idiopathic atrial
fibrillation. Mol Biol Rep. 39:8127–8135. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang YQ, Wang J, Wang XH, Wang Q, Tan HW,
Zhang M, Shen FF, Jiang JQ, Fang WY and Liu X: Mutational spectrum
of the GATA5 gene associated with familial atrial fibrillation. Int
J Cardiol. 157:305–307. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang YQ, Wang XH, Tan HW, Jiang WF, Fang
WY and Liu X: Prevalence and spectrum of GATA6 mutations associated
with familial atrial fibrillation. Int J Cardiol. 155:494–496.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang YQ, Li L, Wang J, Zhang XL, Li RG, Xu
YJ, Tan HW, Wang XH, Jiang JQ, Fang WY and Liu X: GATA6
loss-of-function mutation in atrial fibrillation. Eur J Med Genet.
55:520–526. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li J, Liu WD, Yang ZL and Yang YQ: Novel
GATA6 loss-of-function mutation responsible for familial atrial
fibrillation. Int J Mol Med. 4:783–790. 2012.PubMed/NCBI
|
|
42
|
Delmar M and Makita N: Cardiac connexins,
mutations and arrhythmias. Curr Opin Cardiol. 27:236–241. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jansen JA, van Veen TA, de Bakker JM and
van Rijen HV: Cardiac connexins and impulse propagation. J Mol Cell
Cardiol. 48:76–82. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Vozzi C, Dupont E, Coppen SR, Yeh HI and
Severs NJ: Chamber-related differences in connexin expression in
the human heart. J Mol Cell Cardiol. 31:991–1003. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hagendorff A, Schumacher B, Kirchhoff S,
Lüderitz B and Willecke K: Conduction disturbances and increased
atrial vulnerability in Connexin40-deficient mice analyzed by
transesophageal stimulation. Circulation. 99:1508–1515. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
van der Velden HM, Ausma J, Rook MB,
Hellemons AJ, van Veen TA, Allessie MA and Jongsma HJ: Gap
junctional remodeling in relation to stabilization of atrial
fibrillation in the goat. Cardiovasc Res. 46:476–486.
2000.PubMed/NCBI
|
|
47
|
Severs NJ, Coppen SR, Dupont E, Yeh HI, Ko
YS and Matsushita T: Gap junction alterations in human cardiac
disease. Cardiovasc Res. 62:368–377. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Groenewegen WA, Firouzi M, Bezzina CR,
Vliex S, van Langen IM, Sandkuijl L, Smits JP, Hulsbeek M, Rook MB,
Jongsma HJ and Wilde AA: A cardiac sodium channel mutation
cosegregates with a rare connexin40 genotype in familial atrial
standstill. Circ Res. 92:14–22. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Firouzi M, Ramanna H, Kok B, Jongsma HJ,
Koeleman BP, Doevendans PA, Groenewegen WA and Hauer RN:
Association of human connexin40 gene polymorphisms with atrial
vulnerability as a risk factor for lone atrial fibrillation. Circ
Res. 95:e29–e33. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Juang JM, Chern YR, Tsai CT, Chiang FT,
Lin JL, Hwang JJ, Hsu KL, Tseng CD, Tseng YZ and Lai LP: The
association of human connexin 40 genetic polymorphisms with atrial
fibrillation. Int J Cardiol. 116:107–112. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wirka RC, Gore S, Van Wagoner DR, Arking
DE, Lubitz SA, Lunetta KL, Benjamin EJ, Alonso A, Ellinor PT,
Barnard J, Chung MK and Smith JD: A common connexin-40 gene
promoter variant affects connexin-40 expression in human atria and
is associated with atrial fibrillation. Circ Arrhythm
Electrophysiol. 4:87–93. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chaldoupi SM, Hubens LE, Smit
Duijzentkunst DA, van Stuijvenberg L, Bierhuizen MF, van Aarnhem
EE, Nelen M, de Bakker JM, Hauer RN, van Rijen HV, Loh P and van
Veen TA: Reduced connexin40 protein expression in the right atrial
appendage of patients bearing the minor connexin40 allele (-44G→A).
Europace. 14:1199–1205. 2012.PubMed/NCBI
|
|
53
|
Gollob MH, Jones DL, Krahn AD, Danis L,
Gong XQ, Shao Q, Liu X, Veinot JP, Tang AS, Stewart AF, Tesson F,
Klein GJ, Yee R, Skanes AC, Guiraudon GM, Ebihara L and Bai D:
Somatic mutations in the connexin 40 gene (GJA5) in atrial
fibrillation. N Engl J Med. 354:2677–2688. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yang YQ, Zhang XL, Wang XH, Tan HW, Shi
HF, Jiang WF, Fang WY and Liu X: Connexin40 nonsense mutation in
familial atrial fibrillation. Int J Mol Med. 26:605–610.
2010.PubMed/NCBI
|
|
55
|
Yang YQ, Liu X, Zhang XL, Wang XH, Tan HW,
Shi HF, Jiang WF and Fang WY: Novel connexin40 missense mutations
in patients with familial atrial fibrillation. Europace.
12:1421–1427. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Chugh SS, Blackshear JL, Shen WK, Hammill
SC and Gersh BJ: Epidemiology and natural history of atrial
fibrillation: clinical implications. J Am Coll Cardiol. 37:371–378.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chaldoupi SM, Loh P, Hauer RN, de Bakker
JM and van Rijen HV: The role of connexin40 in atrial fibrillation.
Cardiovasc Res. 84:15–23. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Bagwe S, Berenfeld O, Vaidya D, Morley GE
and Jalife J: Altered right atrial excitation and propagation in
connexin40 knockout mice. Circulation. 112:2245–2253. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Rossman EI, Liu K, Morgan GA, Swillo RE,
Krueger JA, Gardell SJ, Butera J, Gruver M, Kantrowitz J, Feldman
HS, Petersen JS, Haugan K and Hennan JK: The gap junction modifier,
GAP-134, improves conduction and reduces atrial
fibrillation/flutter in the canine sterile pericarditis model. J
Pharmacol Exp Ther. 329:1127–1133. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Shiroshita-Takeshita A, Sakabe M, Haugan
K, Hennan JK and Nattel S: Model-dependent effects of the gap
junction conduction-enhancing antiarrhythmic peptide rotigaptide
(ZP123) on experimental atrial fibrillation in dogs. Circulation.
115:310–318. 2007. View Article : Google Scholar
|
|
61
|
Igarashi T, Finet JE, Takeuchi A, Fujino
Y, Strom M, Greener ID, Rosenbaum DS and Donahue JK: Connexin gene
transfer preserves conduction velocity and prevents atrial
fibrillation. Circulation. 125:216–225. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zipes DP, Mihalick MJ and Robbins FT:
Effects of selective vagal stellate ganglion stimulation on atrial
refractoriness. Cardiovasc Res. 8:647–655. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Fritz S, Kunz L, Dimitrijevic N, Grunert
R, Heiss C and Mayerhofer A: Muscarinic receptors in human
luteinized granulosa cells: activation blocks gap junctions and
induces the transcription factor early growth response factor-1. J
Clin Endocrinol Metab. 87:1362–1367. 2002. View Article : Google Scholar
|
